The test is designed to detect biomarkers for early diagnosis of pancreatic cancer, improving patients’ prognosis.
The study classified two diagnostic panels based on microRNAs in whole blood.
More Articles on Gastroenterology:
Looking Beyond the Scope: Integrated Care & Women’s Health in Gastroenterology
Cost-Effective Question: FMT vs. Antibiotics
6 Statistics on Colorectal Cancer Diagnosis & Mortality
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
